Bafna Pharmaceuticals Limited (BAFNAPH.NS)
INR 78.05
(-4.33%)
INR 78.05
(-4.33%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.52 Billion | 1.15 Billion | 851.4 Million | 712.17 Million | 424.72 Million | 433.58 Million |
| Cost of Revenue | 1.07 Billion | 765.94 Million | 512.85 Million | 454.55 Million | 270.23 Million | 345.69 Million |
| Gross Profit | 452.15 Million | 387.55 Million | 338.54 Million | 257.62 Million | 154.48 Million | 87.89 Million |
| Operating Expenses | 455.58 Million | 283.74 Million | 274.19 Million | 196.24 Million | 174.09 Million | 159.13 Million |
| Selling, General and Administrative Expenses | 199.13 Million | 20.42 Million | 39.23 Million | 13.69 Million | 15.79 Million | 13.56 Million |
| Research and Development Expenses | 15.36 Million | 7.21 Million | 14.72 Million | 13.58 Million | 10.09 Million | 7.52 Million |
| Other Expenses | 455.58 Million | 32.72 Million | 12.6 Million | 74 Thousand | 75 Thousand | 4.08 Million |
| Cost and Expenses | 1.28 Billion | 1.04 Billion | 787.05 Million | 650.79 Million | 444.33 Million | 504.82 Million |
| Operating Income | 237.66 Million | 117.72 Million | 66.41 Million | 61.45 Million | -19.74 Million | -162.81 Million |
| Interest Expense | 22.9 Million | 20.37 Million | 5.24 Million | 886 Thousand | 10 Thousand | 19.68 Million |
| Income Tax Expense | - | 2.78 Million | 12.56 Million | -2.3 Million | 229.7 Million | 10.67 Million |
| Earnings before Tax | 73.47 Million | 116.16 Million | 73.07 Million | 58.26 Million | -18.83 Million | -182.92 Million |
| Net Income | 73.47 Million | 113.38 Million | 52.16 Million | 58.26 Million | -247.29 Million | -188.7 Million |
| Earnings Per Share Basic | 3.11 | 4.79 | 2.21 | 2.46 | -104.54 | -7.98 |
| Earnings Per Share Diluted | 3.11 | 4.79 | 2.21 | 2.46 | -104.54 | -7.98 |
| Weighted Average Shares Outstanding | 23.62 Million | 23.65 Million | 23.65 Million | 23.65 Million | 2.36 Million | 23.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 23.62 Million | 23.65 Million | 23.65 Million | 23.65 Million | 2.36 Million | 23.65 Million |
| Gross Margin | 0.30 | 0.34 | 0.40 | 0.36 | 0.36 | 0.20 |
| EBIT Margin | 0.08 | 0.16 | 0.16 | 0.15 | 0.03 | -0.08 |
| Profit Margin | 0.05 | 0.10 | 0.06 | 0.08 | -0.58 | -0.44 |
| EBITDA | 114.58 Million | 189.88 Million | 115.03 Million | 106.23 Million | 13.89 Million | -126.9 Million |
| Earnings Before Tax Margin | 0.16 | 0.10 | 0.08 | 0.09 | -0.05 | -0.38 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 332.86 Million | 1.52 Billion | 413.98 Million | 284.42 Million | 406.78 Million | 419.47 Million |
| Cost of Revenue | 316.76 Million | 1.3 Billion | 348.85 Million | 232.91 Million | 287.93 Million | 265.83 Million |
| Gross Profit | 16.09 Million | 215.35 Million | 65.12 Million | 51.5 Million | 118.84 Million | 153.64 Million |
| Operating Expenses | 21.87 Million | 154.19 Million | 48.95 Million | 84.96 Million | 91.21 Million | 102.81 Million |
| Selling, General and Administrative Expenses | 18.42 Million | - | 48.95 Million | 26.96 Million | 30.32 Million | 42.73 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -3.45 Million | 35.22 Million | 5.15 Million | 9.79 Million | 1.59 Million | 18.69 Million |
| Cost and Expenses | 338.64 Million | 1.46 Billion | 397.81 Million | 317.88 Million | 379.15 Million | 368.64 Million |
| Operating Income | -5.77 Million | 61.15 Million | 16.16 Million | -23.66 Million | 29.21 Million | 50.82 Million |
| Interest Expense | 6.51 Million | 22.9 Million | 6.76 Million | 5.75 Million | 4.37 Million | 6 Million |
| Income Tax Expense | - | 49.78 Million | 12.66 Million | 12.74 Million | 12.28 Million | 18.69 Million |
| Earnings before Tax | -7.23 Million | 73.47 Million | 14.55 Million | -29.42 Million | 24.83 Million | 63.51 Million |
| Net Income | -7.23 Million | 73.47 Million | 14.55 Million | -29.42 Million | 24.83 Million | 63.51 Million |
| Earnings Per Share Basic | -0.31 | - | 0.62 | -1.24 | 1.05 | 2.68 |
| Earnings Per Share Diluted | -0.31 | - | 0.62 | -1.24 | 1.05 | 2.68 |
| Weighted Average Shares Outstanding | 23.65 Million | 23.62 Million | 23.65 Million | 23.65 Million | 23.65 Million | 23.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 23.65 Million | 23.62 Million | 23.65 Million | 23.65 Million | 23.65 Million | 23.65 Million |
| Gross Margin | 0.05 | 0.14 | 0.16 | 0.18 | 0.29 | 0.37 |
| EBIT Margin | 0.03 | - | 0.07 | -0.04 | 0.10 | 0.19 |
| Profit Margin | -0.02 | 0.05 | 0.04 | -0.10 | 0.06 | 0.15 |
| EBITDA | 8.66 Million | - | 28.87 Million | -10.95 Million | 41.62 Million | 81.64 Million |
| Earnings Before Tax Margin | -0.02 | 0.04 | 0.04 | -0.08 | 0.07 | 0.12 |
TND
KCP
300676
PTC
RITCO
003460